Macrogenics (MGNX) Capital Expenditures Growth (3y) (2015 - 2026)
Macrogenics (MGNX) Capital Expenditures Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 15.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.96% |
| Dec 31, 2025 | -50.73% |
| Sep 30, 2025 | -26.67% |
| Jun 30, 2025 | -32.32% |
| Mar 31, 2025 | -37.05% |
| Dec 31, 2024 | 12.20% |
| Sep 30, 2024 | 46.78% |
| Jun 30, 2024 | -28.05% |
| Mar 31, 2024 | -27.15% |
| Dec 31, 2023 | -28.22% |
| Jun 30, 2023 | 33.39% |
| Mar 31, 2023 | -47.92% |
| Dec 31, 2022 | 28.71% |
| Sep 30, 2022 | 1.02% |
| Jun 30, 2022 | 19.87% |
| Mar 31, 2022 | -5.47% |
| Dec 31, 2021 | -15.01% |
| Sep 30, 2021 | -37.90% |
| Jun 30, 2021 | -27.85% |
| Mar 31, 2021 | -64.93% |